Officials estimated that 228 fewer babies younger than 3 months older were hospitalized for serious RSV infection during the ...

For infants born from October to February, maternal vaccination was cost-effective, but compared with vaccination, nirsevimab ...

Sanofi’s shift to immunology, AI-driven R&D, and strong pipeline offset risks from patent cliffs and legal issues. See why ...

Pregnant individuals commonly reported hesitancy toward RSVpreF and nirsevimab, indicating the need for efforts to promote the safety and uptake of RSV immunization.

Data shows Australia has already logged a record number of cases this year. NHS chiefs believe the Australian winter is a ...

For newborns and infants, whose immune systems are still developing, and airways are small, RSV can quickly become serious.

Around 100 community pharmacies in the East of England and the Midlands are also now delivering the RSV vaccine, with NHS England planning to expand this offer to up to 150 additional pharmacies ...

RSV is a leading cause of infant mortality around the world and a main cause of child hospitalisations every year ...

THOUSANDS of Brits are being urged to take up a jab that protects against a sometimes deadly “cold-like” virus. The vaccine for respiratory syncytial virus (RSV) is offered to pregnant ...

Vermont has the second lowest state fatality rate in the US (148.5 per 100K; Hawaii 114/100K). Mississippi (466.2/100K) and ...

The CDC expanded RSV vaccine recommendations to include adults aged 50 and above who have underlying health conditions ...

The study found the program was more than 85% effective in reducing infant hospitalizations, emergency-room consultations and ...